Table 3

Demographic and clinical factors associated with treatment outcome

VariableProcedural failure (n=193)Procedural success (n=139)†P value*
Procedure (n, % of procedure type)0.058§
 Facet interventions‡68 (67.3)33 (32.7)
  Radiofrequency ablation29/58 (50)29/58 (50)
 Sacroiliac joint injection33 (50)33 (50)
 ESI92 (55.8)73 (44.2)
  Transforaminal38/79 (48.1)41/79 (51.9)
  Interlaminar53/85 (62.4)32/85 (37.6)
Age, years (mean±SD)50±1354±160.019
Sex, n (%)0.38
 Female108 (60.3)71 (39.7)
 Male85 (55.6)68 (44.4)
Duration of pain, years (mean±SD)6.7±7.74.7±5.70.01
Obesity, n (%)97 (64.2)54 (35.8)0.039
Bilateral symptoms, n (%)86 (61.9)53 (38.1)0.039
Smoking, n (%)59 (75.6)19 (24.4)<0.001
Inciting event, n (%)76 (63.3)44 (36.7)0.15
Opioid use, n (%)42 (65.6)22 (34.4)0.18
Non-opioid use, n (%)¶
 Any adjuvant138 (55.2)112 (44.8)0.059
 Neuropathic adjuvant61 (63.5)35 (36.5)0.2
 Non-steroidal anti-inflammatory drug87 (51.5)82 (48.5)0.012
 Muscle relaxant29 (49.2)30 (50.8)0.12
 Other non-opioid analgesic15 (51.7)14 (48.3)0.46
 Tramadol32 (66.7)16 (33.3)0.2
Active duty, n (%)31 (57.4)23 (42.6)0.12
Disability, worker’s compensation or medical board, n (%)**61 (70.1)26 (29.9)0.009
Coexisting chronic pain conditions, n (%)††
 Any pain condition122 (60.4)80 (39.6)0.3
 Neck pain32 (58.2)23 (41.8)0.99
 Headache17 (63.0)10 (37.0)0.6
 Arthralgia73 (59.8)49 (40.2)0.63
 Neuropathy19 (55.9)15 (44.1)0.78
 Abdominal/pelvic pain7 (87.5)1 (12.5)0.088
 Fibromyalgia8 (57.1)6 (42.9)0.94
 Other chronic pain‡‡20 (80.0)5 (20.0)0.021
 Multiple pain conditions28 (65.1)15 (34.9)0.32
Coexisting psychiatric condition, n (%)§§
 Any psychiatric condition96 (66.2)49 (33.8)0.009
 Anxiety47 (65.3)25 (34.7)0.16
 Depression56 (70.9)23 (29.1)0.008
 Posttraumatic stress disorder11 (78.6)3 (21.4)0.11
 Substance abuse22 (75.9)7 (24.1)0.043
 Other12 (75.0)4 (25.0)0.16
 Multiple psychiatric conditions33 (71.7)13 (28.3)0.044
Non-organic signs (mean, SD)¶¶0.9±1.30.5±1.00.004
Expectations (mean±SD)***3.9±1.33.8±1.30.31
Athens Insomnia Scale (mean±SD)10±58±5<0.001
Quick Inventory of Depressive Symptomatology (QIDS; mean±SD)13±89±7<0.001
Oswestry Disability Score (mean±SD)42±1735±15<0.001
Procedure-related pain (mean, SD
 Skin wheal4.5±2.74.1±2.70.21
 Procedure5.9±3.04.6±2.6<0.001
Average baseline back pain score (mean±SD)6.3±2.05.6±2.00.002
Worst baseline back pain score (mean±SD)8.8±1.78.1±2.20.001
Average baseline leg pain score (mean±SD)†††6.2±2.05.4±1.80.006
Worst baseline leg pain score (mean±SD)†††8.8±1.68.1±1.60.005
  • *Based on t-test for continuous variables and χ2 test for categorical variables.

  • †Procedural success defined as ≥2-point decrease in baseline average low back or leg pain score at 1 month after sacroiliac joint and epidural steroid injections, respectively, or low back pain score 3 months after radiofrequency ablation (or medical branch blocks for patients with sustained relief) for lumbar facet joint pain, coupled with >3/5 score on a Likert satisfaction scale.

  • ‡Negative facet interventions include negative RFA outcome and negative facet blocks in patients who did not obtain long-term relief (n=1).

  • §Comparison among procedural success for facet RFA at 3 months, SIJ injection at 1 month, and ESI at 1 month.

  • ¶Neuropathic adjuvants include anticonvulsants and antidepressants. Non-steroidal anti-inflammatory drugs include acetaminophen. Other non-opioid analgesics include topical agents such as lidocaine and capsaicin.

  • **Military equivalent of civilian disability.

  • ††Denotes active condition (ie, being treated).

  • ‡‡Other pain conditions include plantar fasciitis, central pain, persistent postsurgical pain and atypical chest pain.

  • §§Denotes active condition (ie, being treated) except for substance abuse.

  • ¶¶Non-organic signs based on five categories of Waddell signs.

  • ***Expectations based on a 6-point Likert scale.

  • †††Leg pain score only recorded for ESIs.

  • ESI, epidural steroid injection; RFA, radiofrequency ablation.